Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2146
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZerroug, Ilhem-
dc.contributor.authorBourfaa, Nesrine-
dc.contributor.authorRabti, Hadjira-
dc.date.accessioned2023-03-13T07:39:00Z-
dc.date.available2023-03-13T07:39:00Z-
dc.date.issued2020-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/2146-
dc.description.abstractIn the context of increasing the intentional solubility of the drug, the main goal of our thesis was to demonstrate the effect of cyclodextrin and its derivatives on improving the solubility of drugsBCS class II known for their low solubility in water which hamper bioavailability, by performing a solubility test and determining the stability constant, in addition to the determination of the binding stoichiometry between the drug and cyclodextrin. To do this, we have gathered recent studies in this field of six different drugs for several researchers and organized them in the form of a literature review. We then studied the solubility of indomethacin in the presence of β-cyclodextrin after validation of the analytical method used. The result of our work showed an improvement in the solubility of the drug in the presence of β-cyclodextrin (15 mmol / L) to double with a constant of 418.067 mol / L and a molar ratio of 1:1en_US
dc.language.isofren_US
dc.publisherUniversité constantine 3 Salah boubnider, Faculté génie des procédésen_US
dc.subjectcyclodextrinen_US
dc.subjectsolubilityen_US
dc.subjectβ-cyclodextrinen_US
dc.subjectindomethacinen_US
dc.titleamelioration de solubilite des medicaments BCS class par les cyclodextrines cas de l'indometacineen_US
Appears in Collections:Génie des procédés / هندسة الطرائق



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.